The authors would like to draw the reader's attention to the errors in the following article:
Zhang W, Li F, Gao W. New data highlighting the efficacy and safety outcomes of third‐generation EGFR‐TKI in NSCLC patients with rare EGFR mutations. Thoracic Cancer 2020; 11: 495–7. https://doi.org/10.1111/1759-7714.13334.
The article should have two corresponding authors.
Below are the complete corresponding authors' information:
Correspondence
Fengtan Li, Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China.
Email: tjzyybjylb@163.com
Wenyuan Gao, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Email: pharmgao@tju.edu.cn
These errors were corrected in the online version of the article.
The authors apologize for these errors and any confusion these may have caused.